Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus

- Systemic Lupus Erythematosus
- Terminated

Study Title: A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus

Teva Identifier: TV-4710/201

ClinicalTrials.gov Identifier: NCT00203151

Study Status: Terminated

Trial Condition(s): Systemic Lupus Erythematosus

Interventions: Drug: edratide

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 18 Years to 65 Years

Trial Duration: 07/01/2005 - 02/01/2007

Phase: Phase 2

Study Type

Interventional